<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00223041</url>
  </required_header>
  <id_info>
    <org_study_id>001</org_study_id>
    <nct_id>NCT00223041</nct_id>
  </id_info>
  <brief_title>Cranoc Lipid Study in Renal Transplantation</brief_title>
  <official_title>Cardiovascular Events in Renal Transplant Recipients With Low LDL-cholesterol Receiving Tacrolimus in Combination With the Statin Fluvastatin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiovascular disease after renal transplantation is an important problem. Patients after
      renal transplantation with low LDL-Levels (&lt;130mg/dl) receive Fluvastatin 80mg/day (or no
      medication, to look for the cardiovascular outcome with and without statins.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease after renal transplantation is an important problem. Patients after
      renal transplantation with low LDL-Levels (&lt;130mg/dl) receive Fluvastatin 80mg/day (or no
      medication, to look for the cardiovascular outcome with and without statins.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    No possibilty to receive all plened patients for this study
  </why_stopped>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cardivasculary events (cardiovaskulary, cerebrovaskulary, peripher vaskulary)</measure>
    <time_frame>during the study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>patients and kidney survival</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>amount and typ of rejection (Banff-classifikation)</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in lipids</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events of the statin fluvastatin</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Renal Transplantation</condition>
  <arm_group>
    <arm_group_label>A (therapy with fluvastatin 80mg retard)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>kidney transplants receive in addition fluvastatin 80mg retard for 3 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no therapy with fluvastatin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluvastatin</intervention_name>
    <description>Arm A receives fluvastatin Arm b receives no fluvastatin</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients (18 - 65, inclusive)

          -  cadaver and living kidney transplantation (1. Ntx, 2. Ntx)

          -  LDL-cholesterol ≤ 130mg/dl (-3 Mo until start of Tx)

          -  Patients with a history of Myocard infarct: LDL-Cholesterol ≤ 110mg/dl

          -  Immunsuppression: Tacrolimus in combination with steroids or Mycophenolat Mofetil

          -  patients indulgence

        Exclusion Criteria:

          -  statin before the study

               -  LDL-Cholesterol &gt;130mg/dl before transplantation

               -  Instabil Angina, Myocard infarct &lt;6 months before transplantation

               -  symptomatic Hypothyreosis

               -  child bearing, lactating

               -  elavated liver encymes (&gt; 2x elavated: AST, ALT, bilirubine, PCK)

               -  Fibrates are not allowed

               -  multiorgantransplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lutz Renders, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Scghleswig-Holstein, Campus Kiel, Department of Nephrology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Schleswig-Holstein, Campus Kiel, Department of Nephrology</name>
      <address>
        <city>Kiel</city>
        <zip>24251</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>August 4, 2011</last_update_submitted>
  <last_update_submitted_qc>August 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2011</last_update_posted>
  <responsible_party>
    <name_title>L. Renders</name_title>
    <organization>University of Kiel, department of Nephrology</organization>
  </responsible_party>
  <keyword>renal transplantation</keyword>
  <keyword>cardiovasculary disease</keyword>
  <keyword>statin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

